Cameorn EA，Binnie JA，Balmy K，et al. Oral prednisolone metasulphobenaoate in the teratment of active ulcerative coiltis[J]. Scand J Castroenterol，2003，38：535537.
[3]Okamura S，Aoki H，Ohashi S，et al. Efficacy of cyclosporin with corticotropin for refractony ulcerative colifis[J]. Hepatogastroenterology，2003，50(49)：9194.
[4]Gionchetit P，RiaacHo F，Momeli C，st al. Management of infleromatory bowel disease：does rifaximin offer any promise[J]. Chemotherapy，2005，11：96100.
[5]刘伟. 溃疡性结肠炎的药物治疗现状与前景.[J] 国外医学·消化系疾病分册，2003，23(5)：261263.
[6]Dhaens G，Lemmens L，Geboes K，et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe atfacks of ulcerative colitis[J]. Gastroenterology，2001，120(6)：13231329.
[7]Sood A，Midha V，Sood N，et al. Cyclosporine in the treatment of severe steroid refractory ulcerative colitis：a retrospective analysis 24 cases[J]. Indian J Gastroenterol. 2008，27(6)：232235.
[8]Jarnerot G. Infliximab or cyclosporine for severe ulcerative colitis[J]. Gastroenterology，2006，130：286287.
[9]Jarnerot G，Hertervig E，FrijsLiby I. et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis：a randomized，placebocontrolled study[J]. Gastroenterology，2005，128：18051811.
[10]Dídia C，Marcelo C，Geraldo E. et al. Infliximab to treat severe ulcerative colitis[J]. World J Gastroenterol，2009，15(14)：17711773.
[11]Targan SR，Hanauer SB，van Deventer SJ，et al. A shortterm study of chimeric monoclonal antibody cA2 to tumor necrosisfactor alpha for Crohns disease[J]. N Engl J Med，1997，(337)：10291035.
[12]D’Haens G，Van Deventer S，Van Hogezand R，et al. Endoscopic and histological healing with infliximab antitumor necrosis factor antibodies in Crohns disease：A European multicenter trial[J]. Gastroenterology，1999，l(16)：10291034.
[13]Comerford LW，Bickston SJ. Treatment of Iuminal and fistulizing Crohn’s disease with Infliximab[J
上一页 [1] [2] [3] [4] [5] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文